- Home
- ALRM vs GLPG Comparison
ALRM vs GLPG Comparison
Compare ALRM & GLPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALRM | GLPG |
|---|---|---|
| Founded | 2000 | 1999 |
| Country | United States | Belgium |
| Employees | N/A | 704 |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.0B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | ALRM | GLPG |
|---|---|---|
| Price | $44.59 | $28.61 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $56.67 | $36.50 |
| AVG Volume (30 Days) | ★ 382.1K | 156.2K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 7.42 | N/A |
| EPS | ★ 2.46 | N/A |
| Revenue | ★ $1,011,187,000.00 | N/A |
| Revenue This Year | $7.00 | N/A |
| Revenue Next Year | $4.53 | N/A |
| P/E Ratio | $17.64 | ★ N/A |
| Revenue Growth | ★ 7.59 | N/A |
| 52 Week Low | $41.50 | $24.74 |
| 52 Week High | $59.98 | $37.78 |
Technical Indicators
Market Signals| Indicator | ALRM | GLPG |
|---|---|---|
| Relative Strength Index (RSI) | 47.92 | 37.52 |
| Support Level | $42.14 | $27.98 |
| Resistance Level | $53.18 | $34.04 |
| Average True Range (ATR) | 1.35 | 0.54 |
| MACD | 0.17 | 0.12 |
| Stochastic Oscillator | 51.81 | 41.30 |
Price Performance
Historical ComparisonAbout ALRM Alarm.com Holdings Inc.
Alarm.com Holdings Inc has a cloud-based platform that offers an expansive suite of IoT solutions addressing world-wide opportunities in the residential, multi-family, small business and enterprise commercial markets. It has two reportable segments: Alarm.com & Other. The Alarm.com segment represents the cloud-based Software platforms for intelligently connected property & related solutions. The other segment is focused on researching, developing & offering residential & commercial automation solutions & energy management products & services in adjacent markets. The majority of revenue is from the Alarm.com segment. The platform allows home & business owners to secure their properties and automate & control an array of connected devices.
About GLPG Galapagos NV
Galapagos NV is a fully integrated biotechnology company with operations in Europe and the United States, dedicated to developing medicines focusing on oncology and immunology. The group focuses on unmet medical needs, it synergizes compelling science, technology, and collaborative approaches to create a deep pipeline of medicines. Its clinical pipeline includes: GLPG5101, a CD19 CAR-T product candidate decentralized manufactured, currently in Phase 1/2 in rrNHL; GLPG5301, a BCMA CAR-T product candidate decentralized manufactured, currently in Phase 1 in rrMM; and GLPG3667, a TYK2 inhibitor currently in Phase 2 clinical trial in DM and SLE. It derives maximum revenue from the United States of America.